Study Title: Intravenous (−)-epicatechin reduces myocardial ischemic injury by protecting mitochondrial function
Citation: Yamazaki et al., 2014. International Journal of Cardiology
What the Study Found: This study found that intravenous (−)-epicatechin reduced myocardial infarct size in a rat ischemia-reperfusion model and helped preserve mitochondrial function during reperfusion. It was associated with improved ATP levels, reduced mitochondrial damage, and better overall cellular energy stability following cardiac injury.
What this means in real life: This study shows that protecting mitochondrial function may play a key role in reducing damage after a cardiac event. It highlights that recovery is not just about restoring blood flow, but also about how well cells regain their ability to produce energy.
Related Content:
- Want to understand how cellular energy connects to heart stress and cardiovascular risk? → 4 Risk Factors for Heart Disease and How to Improve Them Through a Better Understanding of Cellular Energy
- Curious how epicatechin is being studied in relation to mitochondrial protection and cellular signaling? → Mitozz, (-)-Epicatechin and “Mitochondrial Support”